Skip to content
Screener

Cytek Biosciences, Inc. CTKB Product — Total Revenue

Other product segments

Service
$46.3M+5.2%

Similar metrics at other companies

Evolv Technologies Holdings, Inc. logo
EVLVProduct revenue — Total Revenue
$7.26M+39.8%
Evolv Technologies Holdings, Inc. logo
EVLVService revenue — Total Revenue
$78.37M+16.6%
Evolv Technologies Holdings, Inc. logo
EVLVSubscription revenue — Total Revenue
$225.99M+11.7%
Evolv Technologies Holdings, Inc. logo
EVLVLicense fee and other revenue — Total Revenue
$987K+34.3%
FuelCell Energy logo
FCELProduct — Revenue Remaining Performance Obligation
$36.1M-63.2%
FAT
FATNProduct — Revenue Remaining Performance Obligation
$3.12M+302%

Other financials

Income statement

See full
Revenue$48.1M+5.6%
Gross profit$28.3M+18.7%
Operating income-$11.4M-7.3%
Net income-$12.2M-118%
EPS (diluted)-$0.09-125%

Balance sheet

See full
Cash & equivalents$73.8M-2.2%
Total debt$17.0M-6.6%
Total equity$322.0M-14.7%
Total assets$446.9M-9.4%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+40.5%
Free cash flow-$849.0K+42.2%

Valuation

See full
Market cap$545.93M+25.6%
Enterprise value$489.11M+29.2%
P/S2.6×+0.4×

Profitability

See full
Gross margin53.2%-1.2pp
Operating margin-21.6%
Net margin-39%
FCF margin-5.8%-11.4pp

Returns & leverage

See full
Return on equity-23%
Debt / equity0.1×0.0×
Current ratio4.5×-0.7×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.

The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053496
Line itemLess than 1 yearGreater than 1 yearTotal
Product revenue$962$962
Service revenue28,24418,05846,302
Total revenue$29,206$18,058$47,264

Item 1. Consolidated Financial Statements (Unaudited)

FAQ

What is Cytek Biosciences, Inc.'s product — total revenue?
Cytek Biosciences, Inc. (CTKB) reported product — total revenue of $962K in Q2 2026.
How has Cytek Biosciences, Inc.'s product — total revenue changed year-over-year?
Cytek Biosciences, Inc.'s product — total revenue increased by 31.8% year-over-year, from $730K to $962K.
What is the long-term trend for Cytek Biosciences, Inc.'s product — total revenue?
Over 3 years (2022 to 2025), Cytek Biosciences, Inc.'s product — total revenue has grown at a 103.4% compound annual growth rate (CAGR), from $664K to $5.59M.
What does product — total revenue mean?
This metric represents the gross total revenue recognized from the sale of products before any deductions for returns or allowances. It provides a comprehensive view of the top-line performance of the product business unit, reflecting the total volume of sales activity. This figure is essential for analyzing the overall market reach and revenue-generating capacity of the company's hardware and consumable offerings.

Ask your AI about Cytek Biosciences, Inc.'s product — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude